Bd announces industry-first ce marked assay for hpv screening from at-home self-collected vaginal samples

Franklin lakes, n.j., may 13, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the industry's first self-collection claim for hpv screening has been ce marked to the ivd directive 98/79/ec.
BDX Ratings Summary
BDX Quant Ranking